Conference abstractPublished 19 Mar 2018
Receptor targeted engineered stem cells: Therapeutic application for cancer and beyond
Harvard Medical School, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Stem cell-based therapies are emerging as a promising strategy to tackle different disease types. We have identified different cell surface receptors on both tumor cells and tumor cell associated endothelial cells and engineered stem cells express bi-specific therapeutic agents that target these receptor types. Using our recently established invasive, recurrent and resection models of primary brain tumors (GBM) and breast and melanoma metastatic tumors in the brain that mimic clinical settings, we show that engineered human mesenchymal stem cells and neural stem cells expressing novel bi-functional proteins or loaded with oncolytic viruses target both the primary and the invasive tumor deposits and have profound anti-tumor effects. These studies demonstrate the strength of utilizing engineered stem cell based receptor targeted therapeutics for developing cancer therapeutics and have implications for developing innovative therapies for different diseases.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Khalid Shah”